Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
AssigneeAbbott Laboratories
InventorsTariq Ghayur, Jije Gu, Peter C. Isaakson
Life of this patent
Estimating the term…
Abstract
The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease.
Claims76
A binding protein comprising a polypeptide chain, wherein said polypeptide chain comprises VD1-(X1)n-VD2-C-(X2)n, wherein;
- VD1 is a first heavy chain variable domain;
- VD2 is a second heavy chain variable domain;
- C is a heavy chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 is an Fc region;
- and
- n is 0 or 1;
- wherein the binding protein is capable of binding a pair of antigens selected from the group consisting of TNF and PGE2, NGF and PGE2, IL-17A and PGE2, IL-1b and PGE2, IL-6 and PGE2, IL-6R and PGE2, VEGF and PGE2, Abeta (seq. 1) and PGE2, Abeta (seq. 2) and PGE2, Abeta (seq. 3) and PGE2, IL-18 and PGE2, PGE2 and PGE2, IL-15 and PGE2, S1P and PGE2, EGFR (seq. 1) and PGE2, EGFR (seq. 2) and PGE2, and IGFR and PGE2.
A binding protein comprising a polypeptide chain, wherein said polypeptide chain comprises VD1-(X1)n-VD2-C-(X2)n, wherein;
- VD1 is a first light heavy chain variable domain;
- VD2 is a second light heavy chain variable domain;
- C is a light chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 does not comprise an Fc region;
- and
- n is 0 or 1;
- wherein the binding protein is capable of binding a pair of antigens selected from the group consisting of TNF and PGE2, NGF and PGE2, IL-17A and PGE2, IL-1b and PGE2, IL-6 and PGE2, IL-6R and PGE2, VEGF and PGE2, Abeta (seq. 1) and PGE2, Abeta (seq. 2) and PGE2, Abeta (seq. 3) and PGE2, IL-18 and PGE2, PGE2 and PGE2, IL-15 and PGE2, S1P and PGE2, EGFR (seq. 1) and PGE2, EGFR (seq. 2) and PGE2, and IGFR and PGE2.
A binding protein comprising first and second polypeptide chains, wherein said first polypeptide chain comprises a first VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first heavy chain variable domain;
- VD2 is a second heavy chain variable domain;
- C is a heavy chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- and
- X2 is an Fc region;
- and
- wherein said second polypeptide chain comprises a second VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first light chain variable domain;
- VD2 is a second light chain variable domain;
- C is a light chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 does not comprise an Fc region;
- and
- n is 0 or 1, wherein the binding protein is capable of binding a pair of antigens selected from the group consisting of TNF and PGE2, NGF and PGE2, IL-17A and PGE2, IL-1b and PGE2, IL-6 and PGE2, IL-6R and PGE2, VEGF and PGE2, Abeta (seq. 1) and PGE2, Abeta (seq. 2) and PGE2, Abeta (seq. 3) and PGE2, IL-18 and PGE2, PGE2 and PGE2, IL-15 and PGE2, S1P and PGE2, EGFR (seq. 1) and PGE2, EGFR (seq. 2) and PGE2, and IGFR and PGE2.
A binding protein capable of binding two antigens comprising four polypeptide chains, wherein two polypeptide chains comprise VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first heavy chain variable domain;
- VD2 is a second heavy chain variable domain;
- C is a heavy chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- and
- X2 is an Fc region;
- and
- wherein two polypeptide chains comprise VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first light chain variable domain;
- VD2 is a second light chain variable domain;
- C is a light chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 does not comprise an Fc region;
- and
- n is 0 or 1;
- wherein the VD1 and VD2 heavy chain variable domains comprise an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 84, 87, 90, 110, and 112 and wherein the VD1 and VD2 light chain variable domains comprise an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83, 85, 88, 91, 111, and 113.
A binding protein capable of binding two antigens comprising four polypeptide chains, wherein two polypeptide chains comprise VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first heavy chain variable domain;
- VD2 is a second heavy chain variable domain;
- C is a heavy chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 is an Fc region;
- and
- n is 0 or 1;
- and
- wherein two polypeptide chains comprise VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first light chain variable domain;
- VD2 is a second light chain variable domain;
- C is a light chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 does not comprise an Fc region;
- and
- n is 0 or 1;
- wherein the DVD-Ig binds at least one antigen selected from the group consisting of Prostaglandin E2 (PGE2), Amyloid beta (Abeta) (seq. 1), Abeta (seq. 2), Abeta (seq. 3), Tumor Necrosis Factor alpha (TNF-α), interleukin 1β (IL-1β), Insulin-like Growth Factor Receptor (IGFR), Interleukin 17A (IL-17A), Interleukin 6 (IL-6), Interleukin 6 receptor (IL-6R), Interleukin 15 (IL-15), Interleukin 18 (IL-18), Nerve Growth Factor (NGF), Epidermal Growth Factor Receptor (EGFR) (seq. 1), EGFR (seq. 2), vascular endothelial growth factor (VEGF), and S1P.
A method for generating a Dual Variable Domain Immunoglobulin capable of binding two antigens comprising the steps of
- a) obtaining a first parent antibody or antigen binding portion thereof, capable of binding a first antigen;
- b) obtaining a second parent antibody or antigen binding portion thereof, capable of binding a second antigen;
- c) constructing first and third polypeptide chains comprising VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first heavy chain variable domain obtained from said first parent antibody or antigen binding portion thereof;
- VD2 is a second heavy chain variable domain obtained from said second parent antibody or antigen binding portion thereof;
- C is a heavy chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 is an Fc region;
- and
- n is 0 or 1;
- and
- d) constructing second and fourth polypeptide chains comprising VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first light chain variable domain obtained from said first parent antibody or antigen binding portion thereof;
- VD2 is a second light chain variable domain obtained from said second parent antibody or antigen binding thereof;
- C is a light chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 does not comprise an Fc region;
- and
- n is 0 or 1;
- and
- e) expressing said first, second, third and fourth polypeptide chains;
- such that a Dual Variable Domain Immunoglobulin capable of binding said first and said second antigen is generated, wherein the binding protein is capable of binding a pair of antigens selected from the group consisting of TNF and PGE2, NGF and PGE2, IL-17A and PGE2, IL-1b and PGE2, IL-6 and PGE2, IL-6R and PGE2, VEGF and PGE2, Abeta (seq. 1) and PGE2, Abeta (seq. 2) and PGE2, Abeta (seq. 3) and PGE2, IL-18 and PGE2, PGE2 and PGE2, IL-15 and PGE2, S1P and PGE2, EGFR (seq. 1) and PGE2, EGFR (seq. 2) and PGE2, and IGFR and PGE2.
A method for generating a Dual Variable Domain Immunoglobulin capable of binding two antigens with desired properties comprising the steps of
- a) obtaining a first parent antibody or antigen binding portion thereof, capable of binding a first antigen and possessing at least one desired property exhibited by the Dual Variable Domain Immunoglobulin;
- b) obtaining a second parent antibody or antigen binding portion thereof, capable of binding a second antigen and possessing at least one desired property exhibited by the Dual Variable Domain Immunoglobulin;
- c) constructing first and third polypeptide chains comprising VD1-(X1)n-VD2-C-(X2)n, wherein;
- VD1 is a first heavy chain variable domain obtained from said first parent antibody or antigen binding portion thereof;
- VD2 is a second heavy chain variable domain obtained from said second parent antibody or antigen binding portion thereof;
- C is a heavy chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 is an Fc region;
- and
- n is 0 or 1;
- d) constructing second and fourth polypeptide chains comprising VD1-(X1)n-VD2-C-(X2)n, wherein;
- VD1 is a first light chain variable domain obtained from said first parent antibody or antigen binding portion thereof;
- VD2 is a second light chain variable domain obtained from said second parent antibody or antigen binding portion thereof;
- C is a light chain constant domain;
- X1 is a linker with the proviso that it is not CH1;
- X2 does not comprise an Fc region;
- and
- n is 0 or 1;
- e) expressing said first, second, third and fourth polypeptide chains;
- such that a Dual Variable Domain Immunoglobulin capable of binding said first and said second antigen with desired properties is generated, wherein the binding protein is capable of binding a pair of antigens selected from the group consisting of TNF and PGE2, NGF and PGE2, IL-17A and PGE2, IL-1b and PGE2, IL-6 and PGE2, IL-6R and PGE2, VEGF and PGE2, Abeta (seq. 1) and PGE2, Abeta (seq. 2) and PGE2, Abeta (seq. 3) and PGE2, IL-18 and PGE2, PGE2 and PGE2, IL-15 and PGE2, S1P and PGE2, EGFR (seq. 1) and PGE2, EGFR (seq. 2) and PGE2, and IGFR and PGE2.
Dependencies are inferred from the claim text.